Research output per year
Research output per year
Fingerprint
Dive into the research topics where Sreyashi Basu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapy
Baruch, E. N., Gleber-Netto, F. O., Nagarajan, P., Rao, X., Akhter, S., Eichwald, T., Xie, T., Balood, M., Adewale, A., Naara, S., Sathishkumar, H. N., Islam, S., McCarthy, W., Mattson, B. J., Ferrarotto, R., Wong, M. K., Davies, M. A., Jindal, S., Basu, S. & Roversi, K. & 41 others, , Aug 20 2025, (E-pub ahead of print) In: Nature.Research output: Contribution to journal › Article › peer-review
6 Scopus citations -
Immune checkpoint inhibitors plus debulking surgery for patients with metastatic renal cell carcinoma: clinical outcomes and immunological correlates of a prospective pilot trial
Goswami, S., Gao, J., Basu, S., Shapiro, D. D., Karam, J. A., Tidwell, R. S., Ahrar, K., Campbell, M. T., Shen, Y., Trevino, A. E., Mayer, A. T., Espejo, A. B., Seua, C., Macaluso, M. D., Chen, Y., Liu, W., He, Z., Yadav, S. S., Wang, Y. & Rao, P. & 7 others, , Dec 2025, In: Nature communications. 16, 1, 1846.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence
Youssef, N., Habeeb, M., Chen, H., Alhamal, Z., Mamlouk, O., Lin, Y., Page, V., Tchakarov, A., Basu, S., Diab, A., Sharma, P. & Abudayyeh, A., 2025, (Accepted/In press) In: Kidney International Reports.Research output: Contribution to journal › Article › peer-review
Open Access -
Investigative needle core biopsies support multimodal deep-data generation in glioblastoma
The GBM TeamLab, Dec 2025, In: Nature communications. 16, 1, 3957.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Loss of PTDSS1 in tumor cells improves immunogenicity and response to anti–PD-1 therapy
Liu, J., Herbrich, S., Basu, S., Chen, Y., Nagarajan, A., Anandhan, S., Goswami, S., Xiong, L., Guan, B. & Sharma, P., Sep 12 2025, In: Science Advances. 11, 37, eadx8134.Research output: Contribution to journal › Article › peer-review
Open Access